These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
508 related articles for article (PubMed ID: 25450711)
1. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. Yeung OW; Lo CM; Ling CC; Qi X; Geng W; Li CX; Ng KT; Forbes SJ; Guan XY; Poon RT; Fan ST; Man K J Hepatol; 2015 Mar; 62(3):607-16. PubMed ID: 25450711 [TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648 [TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma. Zhu F; Li X; Chen S; Zeng Q; Zhao Y; Luo F Med Oncol; 2016 Feb; 33(2):17. PubMed ID: 26781124 [TBL] [Abstract][Full Text] [Related]
4. M2 macrophages on tumour growth and metastasis in hepatocellular carcinoma. Man K; Lo CM; Liu XB Hong Kong Med J; 2019 Dec; 25 Suppl 9(6):35-39. PubMed ID: 31889034 [No Abstract] [Full Text] [Related]
5. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment. Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice. Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367 [TBL] [Abstract][Full Text] [Related]
7. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages. Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516 [TBL] [Abstract][Full Text] [Related]
8. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401 [TBL] [Abstract][Full Text] [Related]
9. Elevated CD163 Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919 [No Abstract] [Full Text] [Related]
10. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target. Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034 [TBL] [Abstract][Full Text] [Related]
12. Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation. Sun B; Zhong FJ; Xu C; Li YM; Zhao YR; Cao MM; Yang LY Cell Death Dis; 2021 Sep; 12(9):849. PubMed ID: 34521817 [TBL] [Abstract][Full Text] [Related]
13. Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer. Liu J; Li C; Zhang L; Liu K; Jiang X; Wang X; Yang L; Liang W; Liu K; Hu J; Li F Diagn Pathol; 2019 Jun; 14(1):55. PubMed ID: 31186031 [TBL] [Abstract][Full Text] [Related]
14. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628 [TBL] [Abstract][Full Text] [Related]
15. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
16. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway. Wang H; Wang X; Li X; Fan Y; Li G; Guo C; Zhu F; Zhang L; Shi Y Cancer Lett; 2014 Apr; 345(1):91-9. PubMed ID: 24333724 [TBL] [Abstract][Full Text] [Related]
17. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469 [TBL] [Abstract][Full Text] [Related]
18. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma. Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648 [TBL] [Abstract][Full Text] [Related]
19. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression. Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Chang RM; Xu JF; Fang F; Yang H; Yang LY Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]